Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-24-036256
Filing Date
2024-09-16
Accepted
2024-09-13 20:25:03
Documents
7

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 2717841
2 form424b3_001.jpg GRAPHIC 11607
3 form10-k_002.jpg GRAPHIC 106726
4 form10-k_003.jpg GRAPHIC 20538
5 form10-k_004.jpg GRAPHIC 20085
6 form10-k_005.jpg GRAPHIC 155967
7 form10-k_001.jpg GRAPHIC 27071
  Complete submission text file 0001493152-24-036256.txt   3190644
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-269414 | Film No.: 241299147
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)